Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q80ZF8

Entry ID Method Resolution Chain Position Source
AF-Q80ZF8-F1 Predicted AlphaFoldDB

46 variants for Q80ZF8

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1134270660 10 Y>* No EVA
rs1135006934 17 L>M No EVA
rs3388460544 183 N>H No EVA
rs3389747213 292 S>F No EVA
rs3389756508 312 Q>H No EVA
rs3413085970 313 V>L No EVA
rs3389756510 315 T>P No EVA
rs3389763473 340 A>T No EVA
rs3389756484 342 C>W No EVA
rs3389734899 343 P>T No EVA
rs3388461610 348 W>S No EVA
rs3388461326 368 R>* No EVA
rs1135064861 376 Q>* No EVA
rs3388460493 485 A>T No EVA
rs3388461478 528 P>S No EVA
rs3389763505 537 C>* No EVA
rs3388460893 628 D>E No EVA
rs3388461025 646 F>C No EVA
rs3388461324 658 K>T No EVA
rs3388460968 663 D>Y No EVA
rs3388461265 674 L>I No EVA
rs3388460675 681 F>Y No EVA
rs3389680737 761 V>* No EVA
rs3388461425 792 I>V No EVA
rs3388461670 804 E>A No EVA
rs3388461050 862 L>W No EVA
rs3388460646 877 P>T No EVA
rs3388461819 945 T>I No EVA
rs3388461072 955 S>L No EVA
rs3388460826 969 A>P No EVA
rs3388461124 984 L>V No EVA
rs3388461395 985 C>* No EVA
rs3388460622 986 L>V No EVA
rs3413090025 993 L>F No EVA
rs3388461595 1030 A>V No EVA
rs3388461503 1091 T>I No EVA
rs3388461110 1098 S>Y No EVA
rs3388460427 1103 C>S No EVA
rs3388461159 1116 A>G No EVA
rs3388461507 1134 V>M No EVA
rs3388461808 1356 M>I No EVA
rs224204028 1361 M>I No EVA
rs3388460588 1419 Y>C No EVA
rs3388461323 1449 D>A No EVA
rs3388460760 1483 T>S No EVA
rs3388461055 1503 W>* No EVA

No associated diseases with Q80ZF8

4 regional properties for Q80ZF8

Type Name Position InterPro Accession
domain Zinc finger, ZZ-type 91 - 146 IPR000433
domain SANT/Myb domain 154 - 198 IPR001005
domain SWIRM domain 471 - 562 IPR007526
domain ADA2-like, zinc finger, ZZ-type 95 - 141 IPR041983

Functions

Description
EC Number
Subcellular Localization
  • Cell membrane ; Multi-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
integral component of plasma membrane The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
postsynapse The part of a synapse that is part of the post-synaptic cell.
synaptic cleft The narrow gap that separates the presynaptic and postsynaptic membranes, into which neurotransmitter is released.

2 GO annotations of molecular function

Name Definition
G protein-coupled receptor activity Combining with an extracellular signal and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.
GTPase activator activity Binds to and increases the activity of a GTPase, an enzyme that catalyzes the hydrolysis of GTP.

9 GO annotations of biological process

Name Definition
adenylate cyclase-activating G protein-coupled receptor signaling pathway A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation of adenylyl cyclase activity and a subsequent increase in the intracellular concentration of cyclic AMP (cAMP).
cell surface receptor signaling pathway The series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
maintenance of synapse structure A process that preserves the structural organistation and orientation of a synaptic cellular component such as the synaptic cytoskeleton and molecular scaffolds.
motor learning Any process in which an organism acquires a novel neuromuscular action or movement as the result of experience.
myoblast fusion A process in which non-proliferating myoblasts fuse to existing fibers or to myotubes to form new fibers. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
negative regulation of angiogenesis Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis.
neuron remodeling The developmentally regulated remodeling of neuronal projections such as pruning to eliminate the extra dendrites and axons projections set up in early stages of nervous system development.
positive regulation of synapse assembly Any process that activates, maintains or increases the frequency, rate or extent of synapse assembly, the aggregation, arrangement and bonding together of a set of components to form a synapse.
regulation of dendrite morphogenesis Any process that modulates the frequency, rate or extent of dendrite morphogenesis.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
O60242 ADGRB3 Adhesion G protein-coupled receptor B3 Homo sapiens (Human) PR
Q80TR1 Adgrl1 Adhesion G protein-coupled receptor L1 Mus musculus (Mouse) PR
10 20 30 40 50 60
MKAVRNLLIY IFSTYLLVMF GFNAAQDFWC STLVKGVIYG SYSVSEMFPK NFTNCTWTLE
70 80 90 100 110 120
NPDPTKYSIY LKFSKKDLSC SNFSLLAYQF DHFSHEKIKD LLRKNHSIMQ LCSSKNAFVF
130 140 150 160 170 180
LQYDKNFIQI RRVFPTDFPG LQKKVEEDQK SFFEFLVLNK VSPSQFGCHV LCTWLESCLK
190 200 210 220 230 240
SENGRTESCG IMYTKCTCPQ HLGEWGIDDQ SLVLLNNVVL PLNEQTEGCL TQELQTTQVC
250 260 270 280 290 300
NLTREAKRPP KEEFGMMGDH TIKSQRPRSV HEKRVPQEQA DAAKFMAQTG ESGVEEWSQW
310 320 330 340 350 360
SACSVTCGQG SQVRTRTCVS PYGTHCSGPL RESRVCNNTA LCPVHGVWEE WSPWSLCSFT
370 380 390 400 410 420
CGRGQRTRTR SCTPPQYGGR PCEGPETHHK PCNIALCPVD GQWQEWSSWS HCSVTCSNGT
430 440 450 460 470 480
QQRSRQCTAA AHGGSECRGP WAESRECYNP ECTANGQWNQ WGHWSGCSKS CDGGWERRMR
490 500 510 520 530 540
TCQGAAVTGQ QCEGTGEEVR RCSEQRCPAP YEICPEDYLI SMVWKRTPAG DLAFNQCPLN
550 560 570 580 590 600
ATGTTSRRCS LSLHGVASWE QPSFARCISN EYRHLQHSIK EHLAKGQRML AGDGMSQVTK
610 620 630 640 650 660
TLLDLTQRKN FYAGDLLVSV EILRNVTDTF KRASYIPASD GVQNFFQIVS NLLDEENKEK
670 680 690 700 710 720
WEDAQQIYPG SIELMQVIED FIHIVGMGMM DFQNSYLMTG NVVASIQKLP AASVLTDINF
730 740 750 760 770 780
PMKGRKGMVD WARNSEDRVV IPKSIFTPVS SKELDESSVF VLGAVLYKNL DLILPTLRNY
790 800 810 820 830 840
TVVNSKVIVV TIRPEPKTTD SFLEIELAHL ANGTLNPYCV LWDDSKSNES LGTWSTQGCK
850 860 870 880 890 900
TVLTDASHTK CLCDRLSTFA ILAQQPREIV MESSGTPSVT LIVGSGLSCL ALITLAVVYA
910 920 930 940 950 960
ALWRYIRSER SIILINFCLS IISSNILILV GQTQTHNKSI CTTTTAFLHF FFLASFCWVL
970 980 990 1000 1010 1020
TEAWQSYMAV TGKIRTRLIR KRFLCLGWGL PALVVATSVG FTRTKGYGTD HYCWLSLEGG
1030 1040 1050 1060 1070 1080
LLYAFVGPAA AVVLVNMVIG ILVFNKLVSR DGILDKKLKH RAGQMSEPHS GLTLKCAKCG
1090 1100 1110 1120 1130 1140
VVSTTALSAT TASNAMASLW SSCVVLPLLA LTWMSAVLAM TDKRSILFQI LFAVFDSLQG
1150 1160 1170 1180 1190 1200
FVIVMVHCIL RREVQDAFRC RLRNCQDPIN ADSSSSFPNG HAQIMTDFEK DVDIACRSVL
1210 1220 1230 1240 1250 1260
HKDIGPCRAA TITGTLSRIS LNDDEEEKGT NPEGLSYSTL PGNVISKVII QQPTGLHMPM
1270 1280 1290 1300 1310 1320
SMNELSNPCL KKENTELRRT VYLCTDDNLR GADMDIVHPQ ERMMESDYIV MPRSSVSTQP
1330 1340 1350 1360 1370 1380
SMKEESKMNI GMETLPHERL LHYKVNPEFN MNPPVMDQFN MNLDQHLAPQ EHMQNLPFEP
1390 1400 1410 1420 1430 1440
RTAVKNFMAS ELDDNVGLSR SETGSTISMS SLERRKSRYS DLDFEKVMHT RKRHMELFQE
1450 1460 1470 1480 1490 1500
LNQKFQTLDR FRDIPNTSSM ENPAPNKNPW DTFKPPSEYQ HYTTINVLDT EAKDTLELRP
1510 1520
AEWEKCLNLP LDVQEGDFQT EV